12-Month Efficacy and Safety of Diepalrestat in Adults With Diabetic Peripheral Neuropathy, a DB, Placebo-Controlled Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Diabetic Peripheral Neuropathy
Interventions
DRUG

diepalrestat choline

aldose reductase inhibitor

DRUG

Placebo

Placebo

Trial Locations (27)

119034

Endocrinology Dispensary, Moscow

119049

Morozovskaya Children City Hospital of Moscow, Moscow

119435

I M Sechenov First Moscow State Medical University, Moscow

IM Sechenov First Moscow State Medical University, Moscow

119991

IM Sechenov First Moscow State Medical University, Moscow

121374

City Clinical Hospital No 71, Moscow

125367

Central Clinical Hospital No 1 of JSC Russian Railway, Moscow

127206

City Clinical Hospital No 50, Moscow

127486

The Federal Bureau of Medical and Social Expertise, Moscow

150000

Regional Clinical Hospital, Yaroslavl

150003

NV Solovyov Clinical Emergency Hospital, Yaroslavl

162600

Health Services Severstal, Cherepovets

163000

Northern State Medical University, Arkhangelsk

185019

VA Baranov Respublical Hospital, Petrozavodsk

191186

Imc Sogaz, Saint Petersburg

194295

Medical Center Reavita, Saint Petersburg

195257

City Hospital of the Holy Martyr Elizabeth, Saint Petersburg

197706

City Hospital No 40 of the Kurortny District, Saint Petersburg

198510

Nikolaev Hospital, Saint Petersburg

344022

Rostov State Medical University, Rostov-on-Don

400131

State Medical University, Volgograd

410053

City Polyclinic No 20, Saratov

432057

Central City Clinical Hospital, Ulyanovsk

450000

Bashkir State Medical University, Ufa

614107

Perm State Medical Academy, Perm

620014

Clinic of Neurology, Yekaterinburg

650066

Kemerovo Regional Clinical Hospital, Kemerovo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

NeuromaxBionevia

INDUSTRY

NCT02332005 - 12-Month Efficacy and Safety of Diepalrestat in Adults With Diabetic Peripheral Neuropathy, a DB, Placebo-Controlled Study | Biotech Hunter | Biotech Hunter